Cingulate INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

27 Mar 2025

CING

10-K: Cingulate Inc. Outlines Financial Strategy and Clinical Pipeline in 2024 10-K Filing

Cingulate Inc.'s 2024 10-K filing details the company's financial status, clinical development plans, and regulatory strategies for its ADHD and anxiety product candidates.

NASDAQ

1 Apr 2024

CING

Cingulate INC

10-K: Cingulate Inc. Details Capital Structure and Regulatory Compliance in 10-K Filing

Cingulate Inc.'s 10-K filing outlines its capital structure, including common and preferred stock, warrants, and compliance with Delaware law and SEC regulations.